Examination of α-SMA+ fibroblasts after ABT-263 treatment of human healthy and IPF PCLS supported enhanced sensitivity and apoptosis that we predicted would occur with the coexpression of antiapoptotic BCL-2 family members in IPF lung tissue. The gene discussed is BCL2; the disease is idiopathic pulmonary fibrosis.